Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.39−0.12 (-1.60%)
Close on Nov 18, 2026Market cap $444.06MP/E –Yield –
Oculis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -CHF 66.30M. The highest annual figure on record is -CHF 12.03M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 66.30M | – |
| FY2024 | Dec 31, 2024 | -CHF 48.92M | – |
| FY2023 | Dec 31, 2023 | -CHF 55.04M | – |
| FY2022 | Dec 31, 2022 | -CHF 25.07M | – |
| FY2021 | Dec 31, 2021 | -CHF 13.83M | – |
| FY2020 | Dec 31, 2020 | -CHF 12.03M | – |
See a number that looks wrong?